5. CONCLUSION:
The small compound eritadenine has exhibited excellent properties against all aforementioned categories of target, toxicity and ADME so it could be propagated as a drug to combat the SARS-CoV-2. Whereas the other compounds also possessed such immunomodulatory properties as mentioned in the existing literature mentioned above. However, this work is foundational, but the results are promising and further studies of these ligands in vitro and in vivo should be studied to decipher the therapeutic role of these compounds.